The data demonstrate, for the first time, positive beta‐cell survival effects of enzymatically stabilized PP peptide analogs, coupled with sustained actions to reduce food intake, endorsing potential therapeutic promise of PP analogs for obesity‐derived forms of diabetes. This evidence concerns the gene PPY and diabetes mellitus.